Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial Journal Article
| Authors: | Kazandjian, D.; Korde, N.; Mailankody, S.; Hill, E.; Figg, W. D.; Roschewski, M.; Landgren, O. |
| Article Title: | Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial |
| Journal Title: | JAMA Oncology |
| Volume: | 4 |
| Issue: | 12 |
| ISSN: | 2374-2437 |
| Publisher: | American Medical Association |
| Date Published: | 2018-12-01 |
| Start Page: | 1781 |
| End Page: | 1783 |
| Language: | English |
| DOI: | 10.1001/jamaoncol.2018.5457 |
| PROVIDER: | scopus |
| PUBMED: | 30477009 |
| PMCID: | PMC6440717 |
| DOI/URL: | |
| Notes: | JAMA Oncol. -- Export Date: 2 January 2019 -- Letter -- Source: Scopus C2 - 30477009 |
